Prospective, Randomized Trial of Epinephrine, Metaproterenol, and Both in the Prehospital Treatment of Asthma in the Adult Patient☆,☆☆,★
Section snippets
INTRODUCTION
Acute bronchospasm in the asthmatic patient is a potentially life-threatening condition that is commonly evaluated and treated by prehospital personnel.1 Although subcutaneous epinephrine was previously considered the treatment of choice for these patients, inhaled β 2-agonists have come to be preferred in many treatment protocols during the last 10 to 15 years.2, 3, 4 In the emergency department setting, β 2-agonists have been shown to be as effective as subcutaneous epinephrine5 and to have
MATERIALS AND METHODS
The study was conducted from October 1992 through June 1993. Our emergency medical service (EMS) provides basic and advanced life support to a largely inner-city population of 400,000, with more than 45,000 patients transported yearly. The EMS has a two-tiered priority response system with paired paramedic crews. There are approximately 14,000 advanced life support calls per year, resulting in 6,000 patient transports. Paramedics treat patients in the field with standing orders for cardiac
RESULTS
During a 9-month period, 197 patients were enrolled in the study, with 154 (78%) patients evaluable. Forty-three patients were considered not evaluable for the following reasons: documentation error (n=18), medication error or protocol not followed (n=11), data incomplete (n=11), patient removed from protocol and intubated (n=2), and unable to treat before arrival at hospital (n=1). Fifty-three (34%) of the evaluable patients were treated with epinephrine, 49 (32%) with metaproterenol, and 52
DISCUSSION
Inhaled β 2-agonist therapy has become first-line treatment for moderate to severe exacerbation of asthma in the ED.3 Epinephrine, however, is still frequently used.4, 10 Paramedics have used subcutaneous epinephrine for the prehospital treatment of acute asthma for many years. Although inhaled β 2-agonists have been added to many prehospital treatment regimens, a recent survey reported that fewer than 50% of urban advanced life support services carry β 2-agonists for inhalation.11 Prospective
CONCLUSION
In this prospective, randomized study of the treatment of moderate to severe exacerbation of asthma in adult patients in the prehospital setting, we found no significant differences in efficacy, as measured by increase in PEFR, among epinephrine, metaproterenol, or both treatments. There appears to be little justification for the simultaneous administration of epinephrine and metaproterenol in the patients we studied. There is a need for critical examination of prehospital treatment of asthma
Acknowledgements
The authors thank the paramedics of the Emergency Medical Services of University Hospital, New Jersey Medical School/University of Medicine and Dentistry of New Jersey, without whose assistance this study would not have been possible.
References (15)
- et al.
Prehospital administration of inhaled metaproterenol
Ann Emerg Med
(1990) - et al.
The emergent approach to asthma
Chest
(1992) - et al.
A controlled trial of nebulized isoetharine in the prehospital treatment of acute asthma
Am J Emerg Med
(1990) - et al.
Prehospital use of inhaled bronchodilators in reversible airway disease (abstract)
Ann Emerg Med
(1989) - et al.
Epinephrine improves expiratory flow rates in patients with asthma who do not respond to inhaled metaproterenol dulfate
J Allergy Clin Immunol
(1989) - et al.
Comparison of peak expiratory flow and FEV 1 admission criteria for acute bronchial asthma
Ann Emerg Med
(1982) - et al.
Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma
Ann Emerg Med
(1982)
Cited by (0)
- ☆
From the University of Medicine and Dentistry of New Jersey*, the Department of Emergency Medicine, University Hospital, The New Jersey Medical School, Newark, New Jersey‡; Section of Trauma and EMS, Department of Surgery, the New Jersey Trauma Center, Newark, New Jersey§; and the Department of Environmental and Community Medicine∥, The Robert Wood Johnson Medical School, Piscataway, New Jersey
- ☆☆
Address for reprints: Mark Quadrel, MD, UMDNJ-University Hospital, Emergency Department-C384, 150 Bergen Street, Newark, New Jersey 07103, 201-982-5129, Fax 201-982-6646
- ★
Reprint no. 47/1/67141